In vivo efficacy of a dry powder formulation of ciprofloxacin-copper complex in a chronic lung infection model of bioluminescent Pseudomonas aeruginosa
Frédéric Tewes, Tania Bahamondez‐Canas, Daniel Moraga-Espinoza, Hugh D. C. Smyth, Alan B. Watts
Topics & Concepts
Pseudomonas aeruginosaIn vivoLungMicrobiologyChemistryCiprofloxacinAgarAgar plateBacteriaDry-powder inhalerAntimicrobialColony-forming unitNuclear chemistryBiologyMedicineImmunologyAntibioticsInternal medicineGeneticsInhalerAsthmaBiotechnologyInhalation and Respiratory Drug DeliveryBacterial biofilms and quorum sensingCystic Fibrosis Research Advances